Surprisingly, our data show that Celastrol is also a highly potent inhibitor of C/EBPβ suggesting that the promising inhibitory effects of Celastrol on AML cells might be due to its ability to simultaneously target Myb and C/EBPβ. The gene discussed is CEBPB; the disease is acute myeloid leukemia.